The efficacy of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) on anhedonia in patients with treatment resistant depression: a phase 2a open label study

Neuroscience Applied 2026 Open access

Read full text

Authors: C. Hindocha, S. McGuigan, M. Seynaeve, A.O. Ermakova, M. Pierce, F. Dunbar, C. Roberts

DOI: 10.1016/j.nsa.2025.105936

Cited by: 1

Fields of Study & Subjects

Neurotransmitter Receptor Influence on Behavior Treatment of Major Depression Tryptophan and brain disorders